Spots Global Cancer Trial Database for b3 and c malignant thymoma
Every month we try and update this database with for b3 and c malignant thymoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy | NCT01301391 | Malignant Thymo... | Milciclib Malea... | 18 Years - | Tiziana Life Sciences LTD | |
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma | NCT01011439 | Thymic Carcinom... | Milciclib Malea... | 18 Years - | Tiziana Life Sciences LTD | |
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma | NCT01011439 | Thymic Carcinom... | Milciclib Malea... | 18 Years - | Tiziana Life Sciences LTD | |
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma | NCT01011439 | Thymic Carcinom... | Milciclib Malea... | 18 Years - | Tiziana Life Sciences LTD |